Gerhard Rogler Selected Research

Crohn Disease (Crohn's Disease)

11/2022	IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus.
1/2022	New Therapeutic Approach for Intestinal Fibrosis Through Inhibition of pH-Sensing Receptor GPR4.
1/2022	MMP9 expression in intestinal fistula from patients with fistulizing CD and from human xenograft mouse model.
1/2022	Depressive Symptoms Predict Clinical Recurrence of Inflammatory Bowel Disease.
8/2021	Genotype-phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients.
2/2021	Perianal fistulodesis - A pilot study of a novel minimally invasive surgical and medical approach for closure of perianal fistulae.
1/2021	Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn's disease: A case series.
1/2021	Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease.
1/2021	The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients.
12/2020	Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerhard Rogler Research Topics

Disease

99	Crohn Disease (Crohn's Disease) 11/2022 - 05/2002
99	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2022 - 09/2003
71	Inflammation (Inflammations) 10/2022 - 09/2003
69	Ulcerative Colitis 01/2022 - 07/2004
56	Colitis 07/2022 - 08/2005
20	Fistula 01/2022 - 02/2009
19	Fibrosis (Cirrhosis) 10/2022 - 06/2007
19	Neoplasms (Cancer) 07/2022 - 05/2006
13	Necrosis 01/2021 - 12/2003
8	Infections 11/2022 - 07/2011
8	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 03/2005
8	Pathologic Constriction (Stenosis) 01/2022 - 02/2009
6	Carcinoma (Carcinomatosis) 01/2022 - 01/2005
6	Hypoxia (Hypoxemia) 05/2021 - 10/2014
6	Rheumatoid Arthritis 01/2021 - 01/2012
6	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 08/2018 - 09/2003
5	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 09/2015
5	Hemorrhage 08/2018 - 05/2007
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 11/2010
4	Osteoporosis 09/2019 - 03/2004
4	Colonic Neoplasms (Colon Cancer) 01/2018 - 03/2005
4	Neuroblastoma 01/2017 - 01/2015
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2015 - 08/2004
3	Proctitis 11/2022 - 01/2009
3	Pain (Aches) 09/2019 - 01/2016

Drug/Important Bio-Agent (IBA)

24	CytokinesIBA 09/2021 - 09/2005
23	Dextrans (Dextran)FDA Link 01/2022 - 09/2005
22	Proteins (Proteins, Gene)FDA Link 10/2022 - 09/2003
21	AntibodiesIBA 01/2022 - 09/2003
19	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2003
16	Messenger RNA (mRNA)IBA 01/2022 - 12/2003
16	SodiumIBA 05/2021 - 08/2005
16	SteroidsIBA 08/2020 - 09/2006
14	Pharmaceutical PreparationsIBA 11/2022 - 01/2012
14	Infliximab (Remicade)FDA Link 07/2022 - 10/2002
13	Interleukin-10 (Interleukin 10)IBA 05/2019 - 09/2006
11	EnzymesIBA 01/2019 - 09/2003
10	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022 - 12/2007
10	Dextran SulfateIBA 09/2021 - 01/2011
9	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022 - 06/2015
9	Protein Tyrosine PhosphatasesIBA 08/2021 - 12/2009
9	Immunologic Factors (Immunomodulators)IBA 01/2021 - 01/2012
9	Azathioprine (Imuran)FDA LinkGeneric 11/2016 - 05/2002
8	Adalimumab (Humira)FDA Link 01/2021 - 01/2010
8	Certolizumab Pegol FDA Link 01/2021 - 06/2010
7	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 10/2014
7	CollagenIBA 01/2022 - 04/2010
7	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 06/2002
7	Interleukin-13IBA 01/2021 - 01/2013
7	Biomarkers (Surrogate Marker)IBA 09/2020 - 01/2014
7	Methotrexate (Mexate)FDA LinkGeneric 03/2020 - 01/2010
7	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 06/2010
7	Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA 01/2018 - 05/2012
6	Interleukin-6 (Interleukin 6)IBA 09/2021 - 06/2006
6	Biological ProductsIBA 01/2021 - 05/2009
6	InterleukinsIBA 01/2021 - 09/2005
6	Polysaccharides (Glycans)IBA 01/2018 - 02/2010
6	NucleotidesIBA 01/2017 - 08/2013
5	LipidsIBA 10/2022 - 01/2017
5	vedolizumabIBA 07/2022 - 01/2020
5	Protons (Proton)IBA 01/2022 - 06/2015
5	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 03/2005
5	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2020 - 09/2013
5	IronIBA 05/2019 - 03/2013
5	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2017 - 04/2011
5	Anthocyanins (Anthocyanin)IBA 01/2017 - 07/2008
5	ImmunosorbentsIBA 11/2016 - 09/2003
5	2-mercaptopurineIBA 01/2016 - 04/2010
5	Acetylmuramyl-Alanyl-IsoglutamineIBA 09/2013 - 01/2007
4	IntegrinsIBA 01/2022 - 10/2013
4	Tacrolimus (Prograf)FDA LinkGeneric 11/2021 - 01/2010
4	Therapeutic UsesIBA 09/2021 - 03/2009
4	Janus Kinase InhibitorsIBA 01/2021 - 01/2020
4	tofacitinibIBA 01/2021 - 01/2020
4	Phenobarbital (Luminal)FDA Link 01/2021 - 09/2005
4	Non-Receptor Type 22 Protein Tyrosine PhosphataseIBA 11/2019 - 01/2013
4	Calcineurin InhibitorsIBA 01/2019 - 01/2012
4	InflammasomesIBA 01/2018 - 01/2014
4	Immunoglobulin A (IgA)IBA 11/2016 - 09/2003
4	Immunoglobulin G (IgG)IBA 11/2016 - 09/2003
4	InterferonsIBA 01/2013 - 01/2005
4	Tranexamic Acid (AMCA)FDA Link 07/2012 - 02/2010
4	ChitinIBA 07/2012 - 02/2010
4	laminaranIBA 07/2012 - 02/2010
4	NF-kappa B (NF-kB)IBA 12/2007 - 08/2004
3	Immune Checkpoint InhibitorsIBA 07/2022 - 08/2020
3	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 08/2014
3	Metronidazole (Metric)FDA LinkGeneric 02/2021 - 03/2014
3	Insulin (Novolin)FDA Link 01/2021 - 03/2013
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 09/2006
3	Interleukin-12 (IL 12)IBA 01/2020 - 01/2013
3	Budesonide (Pulmicort)FDA LinkGeneric 11/2019 - 03/2014

Therapy/Procedure

70	Therapeutics 11/2022 - 06/2002
8	Colectomy 01/2021 - 01/2009
7	Stem Cell Transplantation 01/2017 - 08/2004
5	Aftercare (After-Treatment) 01/2021 - 10/2002
4	Transplantation 05/2019 - 01/2007
3	Immunotherapy 07/2022 - 01/2021
3	Total Parenteral Nutrition 01/2022 - 01/2021
3	Fecal Microbiota Transplantation 11/2019 - 01/2016